Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.

<h4>Background</h4>Breast cancer chemotherapy with high dose alkylating agents is severely limited by their collateral toxicity to crucial normal tissues such as immune and gut cells. Taking advantage of the selective dependence of cancer cells on high glucose and combining glucose depri...

Full description

Bibliographic Details
Main Authors: Maitham A Khajah, Sarah Khushaish, Yunus A Luqmani
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0272449
_version_ 1828112847164407808
author Maitham A Khajah
Sarah Khushaish
Yunus A Luqmani
author_facet Maitham A Khajah
Sarah Khushaish
Yunus A Luqmani
author_sort Maitham A Khajah
collection DOAJ
description <h4>Background</h4>Breast cancer chemotherapy with high dose alkylating agents is severely limited by their collateral toxicity to crucial normal tissues such as immune and gut cells. Taking advantage of the selective dependence of cancer cells on high glucose and combining glucose deprivation with these agents could produce therapeutic synergy.<h4>Methods</h4>In this study we examined the effect of glucose as well as its deprivation, and antagonism using the non-metabolized analogue 2-deoxy glucose, on the proliferation of several breast cancer cell lines MCF7, MDA-MB-231, YS1.2 and pII and one normal breast cell line, using the MTT assay. Motility was quantitatively assessed using the wound healing assay. Lactate, as the end product of anaerobic glucose metabolism, secreted into culture medium was measured by a biochemical assay. The effect of paclitaxel and doxorubicin on cell proliferation was tested in the absence and presence of low concentrations of glucose using MTT assay.<h4>Results</h4>In all cell lines, glucose supplementation enhanced while glucose deprivation reduced both their proliferation and motility. Lactate added to the medium could substitute for glucose. The inhibitory effects of paclitaxel and doxorubicin were significantly enhanced when glucose concentration was decreased in the culture medium, requiring 1000-fold lesser concentration to achieve a similar degree of inhibition to that seen in glucose-containing medium.<h4>Conclusion</h4>Our data show that a synergy was obtained by combining paclitaxel and doxorubicin with glucose reduction to inhibit cancer cell growth, which in vivo, might be achieved by applying a carbohydrate-restricted diet during the limited phase of application of chemotherapy; this could permit a dose reduction of the cytotoxic agents, resulting in greater tolerance and lesser side effects.
first_indexed 2024-04-11T11:56:01Z
format Article
id doaj.art-0e306d984ec949429aeda96b8f02111f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T11:56:01Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-0e306d984ec949429aeda96b8f02111f2022-12-22T04:25:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01178e027244910.1371/journal.pone.0272449Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.Maitham A KhajahSarah KhushaishYunus A Luqmani<h4>Background</h4>Breast cancer chemotherapy with high dose alkylating agents is severely limited by their collateral toxicity to crucial normal tissues such as immune and gut cells. Taking advantage of the selective dependence of cancer cells on high glucose and combining glucose deprivation with these agents could produce therapeutic synergy.<h4>Methods</h4>In this study we examined the effect of glucose as well as its deprivation, and antagonism using the non-metabolized analogue 2-deoxy glucose, on the proliferation of several breast cancer cell lines MCF7, MDA-MB-231, YS1.2 and pII and one normal breast cell line, using the MTT assay. Motility was quantitatively assessed using the wound healing assay. Lactate, as the end product of anaerobic glucose metabolism, secreted into culture medium was measured by a biochemical assay. The effect of paclitaxel and doxorubicin on cell proliferation was tested in the absence and presence of low concentrations of glucose using MTT assay.<h4>Results</h4>In all cell lines, glucose supplementation enhanced while glucose deprivation reduced both their proliferation and motility. Lactate added to the medium could substitute for glucose. The inhibitory effects of paclitaxel and doxorubicin were significantly enhanced when glucose concentration was decreased in the culture medium, requiring 1000-fold lesser concentration to achieve a similar degree of inhibition to that seen in glucose-containing medium.<h4>Conclusion</h4>Our data show that a synergy was obtained by combining paclitaxel and doxorubicin with glucose reduction to inhibit cancer cell growth, which in vivo, might be achieved by applying a carbohydrate-restricted diet during the limited phase of application of chemotherapy; this could permit a dose reduction of the cytotoxic agents, resulting in greater tolerance and lesser side effects.https://doi.org/10.1371/journal.pone.0272449
spellingShingle Maitham A Khajah
Sarah Khushaish
Yunus A Luqmani
Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
PLoS ONE
title Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
title_full Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
title_fullStr Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
title_full_unstemmed Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
title_short Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
title_sort glucose deprivation reduces proliferation and motility and enhances the anti proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro
url https://doi.org/10.1371/journal.pone.0272449
work_keys_str_mv AT maithamakhajah glucosedeprivationreducesproliferationandmotilityandenhancestheantiproliferativeeffectsofpaclitaxelanddoxorubicininbreastcelllinesinvitro
AT sarahkhushaish glucosedeprivationreducesproliferationandmotilityandenhancestheantiproliferativeeffectsofpaclitaxelanddoxorubicininbreastcelllinesinvitro
AT yunusaluqmani glucosedeprivationreducesproliferationandmotilityandenhancestheantiproliferativeeffectsofpaclitaxelanddoxorubicininbreastcelllinesinvitro